• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0 W/SA2.0 25 & DISTAL CATHETER; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PROGAV 2.0 W/SA2.0 25 & DISTAL CATHETER; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FX649T
Device Problem Infusion or Flow Problem (2964)
Patient Problems Failure of Implant (1924); Patient Problem/Medical Problem (2688)
Event Date 08/09/2019
Event Type  Injury  
Manufacturer Narrative
Height: (b)(6).When additional information becomes available a follow up report will be submitted.
 
Event Description
It was reported that the valve was blocked and under draining.The reporter indicated that a 2 month 18 day post operative valve is blocked and under draining.Additional details of the event have not been provided.
 
Manufacturer Narrative
Investigation.Visual inspection: scratches on the outer housing of the valves were observed through the visual inspection.No significant deformations or damage were detected.Permeability test: a permeability test has indicated that the progav 2.0 valve has a blockage and that the shunt assistant 2.0 is permeable.Adjustment test: the progav 2.0 valve was tested and is adjustable to all specified pressures.Braking force and brake function test: the brake functionality test has shown that the brake function is fully operational and the braking force is within the given tolerances.Computer controlled test: to investigate the claim of under-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.Because the progav 2.0 valve is not permeable, a computer controlled test was not possible.The shunt assistant 2.0 operates within the accepted tolerance.Results: first we performed a visual inspection of the progav 2.0 shunt system.No significant deformations or damage of the valves were detected during the visual inspection.Next we tested the permeability and opening pressure of the valves.The progav 2.0 valve was not permeable, therefore the claim of under-drainage could be confirmed.The shunt assistant 2.0 was permeable and operating within specifications.Additionally, we tested the adjustability as well as the brake functionality and brake force of the progav 2.0 valve.The valve operated as expected and met all specifications.Finally, we have dismantled the valves.Inside the progav 2.0 we have found slight build-up of substances (likely protein) inside the shunt assistant 2.0 we have found no visible deposits.Based on our investigation, we confirm that the shunt system was operating in an under-drainage state at the time of our investigation, because of the blockage of the progav 2.0.This is likely due to the deposits observed inside the progav 2.0.As described in scientific literature, the problem encountered is one of the known, inevitable risks of hc-therapy by shunt implants.We can exclude a defect at the time of release.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV 2.0 W/SA2.0 25 & DISTAL CATHETER
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key8962327
MDR Text Key156572882
Report Number3004721439-2019-00213
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K161853
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 09/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/04/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/28/2023
Device Model NumberFX649T
Device Catalogue NumberFX649T
Device Lot Number20037340
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/21/2019
Date Manufacturer Received09/03/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age69 YR
Patient Weight70
-
-